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1 Introduction 
Methods validation is mandatory in order to assess the fitness of purpose of developed analytical method 
such as HPLC, GC, etc. Of core importance at the end of the validation is the evaluation of the reliability of 
the individual results that will be generated during the routine application of the method. Regulatory 
guidelines provide a general framework to assess the validity of a method, but none address the issue of 
results reliability. In this study, a proposed Bayesian approach provides the effective probability of obtaining 
reliable future analytical results over the whole concentration range investigated. This is summarized in a 
single graph: the reliability profile. This Bayesian reliability profile is also compared to a frequentist 
approach derived from the work of Dewé et al. [1]. Furthermore, to illustrate the applicability of the 
Bayesian reliability profile, this approach is applied to a bioanalytical method dedicated to the determination 
of ketoglutaric acid (KG) and hydroxymethylfurfural (HMF) in human plasma by SPE-HPLC-UV.. 
2 Material and methods 
2.1 Bayesian model 
Results of analytical method (k repetitions, j runs, i concentration levels) are assumed providing from a 
normal distribution:   ijkX ~ ( )ijiN σ;,∆   Eq. 1 
The mean of this distribution can be interpreted as the method bias function dependent on the true ith 
concentrations µT,i. The form chosen is thus a linear regression with random slopes and intercepts: 
jiTjij βµα +=∆ ,  Eq. 2 
The regression coefficients for the jth run ( )', jjj βα=β   are assumed coming from the model: 
jβ ~ ),( 2Σθ βσN   Eq. 3 
Finally the following vague priors are defined: 
θ ~ ),0( ΓN  
0Γ =−1  
Σ ~ )2,0001.0(Wishart 2I  
where 2I  represents the 2 x 2 identity matrix and 0Γ =−1  denotes a matrix of 0s that represents a vague 
prior of θ . 
The standard deviation of the results is given as being dependent on the true concentration level: 
( )γµσ iTi ,=  Eq. 4 
The vague prior used is: γ ~ )0001.0,0(N  
Finally, having specified the regulatory or client specifications or acceptance limits (λ), the main aim is to 
obtain the reliability probability (PRel) as a function of the true concentration: 
( )[ ] min,,Rel ,,, PxPP iTjjiijiTijk ≥∀≤+∆=−= µγβαλσµ  Eq. 5 
MCMC sampling is then performed (for example, using R2Winbugs package from R), which allows us to 
obtain the posterior distribution of each parameter. The predictive distribution of the reliability probability 
for any true concentration level is then obtained following the next algorithm. 
2.2 Reliability profile algorithm 
For each concentration level covering the range that is being assessed:  
1. Draw 10,000 regression parameters *jβ  from the posterior distribution of jβ  (Eq. 3) as well as 
10,000 coefficients of the precision function *γ from Eq. 4. 
2. For each of the 10,000 previously selected combination of bias and precision functions, draw 
10,000 results *ijkX  from Eq. 1, which represent a sample of the predictive distribution of the 
results. 
3. Then compute the number of results lying inside the specifications or acceptance limits [ ]λλ ;−  
for each of the 10,000 situations. 
4. The posterior reliability probability ( )dataXPP iij ,,,Rel γσ∆=  at each concentration level is 
finally estimated by the proportion of results out of 10,000 included within the specification limits  
Finally, a graph representing the reliability of the results obtained by a quantitative analytical method over 
the whole concentration range studied can be obtained, and the concentration range over which the method is 
sufficiently reliable can be determined by comparing the posterior reliability probability (PRel) to a minimum 
reliability value (Pmin), for e.g. 95%. 
2.3 Experimental 
In order to illustrate the proposed approach, it was applied in the present study to the validation of an HPLC-
UV assay for the simultaneous quantification of ketoglutaric acid (KG) and hydroxymethylfurfural (HMF) in 
human plasma. The validation design is: 
•  Calibration standards: 5 concentration levels, 2 repetitions per level, 3 runs. 
•  Validation standards: 4 concentration levels, 4 repetitions per level, 3 runs. 
The specification (λ) = +/-20% around the true concentration values of the validation standards. The 
minimum reliability criterion (Pmin) was set at 90% 
3 Results and discussions 
The whole Bayesian procedure described here is applied to the HPLC-UV assay and the reliability profiles 
can be worked out, as illustrated in Figure 1a and 1b for both analytes, respectively. 
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Figure 1 – Reliability profile for (a) KG and (b) HMF depicting on the y-axis the reliability probability (PRel, 
in %) i.e. the probability to obtain future analytical results within pre-specified acceptance limits λ=±20% 
with respect to the true concentration of analytes on the x-axis. Continuous line: Bayesian reliability profile; 
Dotted line: frequentist reliability profile. Dashed horizontal line: minimum reliability probability (Pmin in %) 
set at 90%. 
In these profiles, the minimum reliability criterion (Pmin) of 90% is shown by the dashed horizontal lines. The 
concentration levels with at least 90% reliability define the valid concentration range for KG and HMF and 
consequently represent the lower and upper quantification limits. The valid concentration range using the 
Bayesian algorithm is from 9.4 to 133.3 µg/ml and 8.9 to 133.3 µg/ml for KG and HMF respectively. In 
Figure 1a and 1b, the frequentist reliability profiles are also drawn in order to compare the two approaches. 
As expected, the Bayesian risk and reliability profiles are more conservative. Indeed, this approach not only 
models the probabilities over the whole concentration range studied, but it also includes the uncertainty of 
each parameter involved in the bias and imprecision function and thus appears more strict when compared to 
the frequentist approach. However, one advantage of the Bayesian reliability profile is the possibility of 
knowing the quality of the results of a quantitative analytical method obtained at all concentration levels 
rather than merely at those levels studied in the validation phase. A second advantage of these profiles is that 
the inclusion of the uncertainty of the parameters should ultimately make the decision of validity more 
trustworthy and should lead to an increase in reliability for final users of the results such as clients, patients 
and so on. 
4 Conclusions 
Quantitative analytical methods play a central role as the generated analytical results are used to make highly 
critical decisions such as conformity of products with release or legal specifications. Analytical results might 
also impact the health of a patient or cause the premature ending of preclinical or clinical studies. In this 
study, a novel Bayesian proposition was made in order to evaluate the reliability of analytical methods over a 
defined concentration range. This leads to a reliability profile over which the lower and upper quantification 
limits are appropriately located and thus the analytical method valid range can be obtained by comparison 
with a minimum reliability probability. The comparison of this approach with a frequentist one showed that 
the Bayesian approach was more conservative, a fact that is not inappropriate considering the highly 
important health and financial decisions that will be made using the validated methods in routine 
applications. Finally, the Bayesian approach is in full agreement with the regulatory validation guidelines 
since all the required validation criteria are included. 
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